NCT03456752View on ClinicalTrials.gov

Perioperative Dexamethasone on Postoperative Outcome in IBD

PHASE2CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 13, 2019

Study Completion Date

January 13, 2020

Conditions
Inflammatory Bowel DiseasesDexamethasonePostoperative IleusPostoperative Complications
Interventions
DRUG

Dexamethasone

Dexamethasone 8mg intravenously prior to induction of anesthesia

DRUG

Normal saline

Normal saline 1.6ml intravenously prior to induction of anesthesia

Trial Locations (1)

210000

Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER

NCT03456752 - Perioperative Dexamethasone on Postoperative Outcome in IBD | Biotech Hunter | Biotech Hunter